🇺🇸 FDA
Patent

US 9339495

Methods of increasing tonic inhibition and treating secondary insomnia

granted A61KA61K31/437A61K9/0019

Quick answer

US patent 9339495 (Methods of increasing tonic inhibition and treating secondary insomnia) held by OVID THERAPEUTICS INC. expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/437, A61K9/0019, A61K9/0053, A61K9/7023